(Q42818431)

7 November 2017

title

Anti-tumor immunity generated by tumor cells engineered to express B7-1 via retroviral or adenoviral gene transfer (English)

1 reference

7 November 2017

1 reference

Felzmann T

1

1 reference

7 November 2017

Ramsey WJ

series ordinal

2

1 reference

7 November 2017

Blaese RM

series ordinal

3

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

7 November 2017

1 reference

7 November 2017

volume

135

1 reference

7 November 2017

issue

1

1 reference

7 November 2017

page(s)

1-10

1 reference

Tolerance, danger, and the extended family

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

The role of the CD28 receptor during T cell responses to antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

A safe packaging line for gene transfer: separating viral genes on two different plasmids

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Characterization of murine sarcoma virus (Kirsten) transformation of mouse and human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900274-2

7 January 2021

10.1016/S0304-3835(98)00274-2

Identifiers

DOI

1 reference

7 November 2017

1 reference